Analysis of the Global Biologics API Market

Analysis of the Global Biologics API Market

Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies

RELEASE DATE
25-Jul-2016
REGION
Europe
Research Code: NE20-01-00-00-00
SKU: CM01238-EU-MR_18863
AvailableYesPDF Download

$3,000.00

Special Price $2,250.00 save 25 %

In stock
SKU
CM01238-EU-MR_18863

$3,000.00

$2,250.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose diseases.” Biologic drugs are significantly derived from monoclonal antibodies, recombinant proteins, vaccines, and others (e.g., cell therapy, gene therapy, antibody drug conjugates). In this study, drivers, restraints, and the competitive landscape as well as outsourcing and market and technology trends are discussed. Estimates and forecasts for the global market are provided from 2016 to 2020.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Key Findings

  • Segment Growth Trends
  • Technology Trend and Market Activities
  • In-house vs. Outsourcing

CEO’s Perspective

Market Definitions

An Overview

Global Biologics API Product Segmentation and Therapeutic Categories

  • Monoclonal antibodies
  • Recombinant proteins
  • Biologic vaccines

Antibody and Recombinant Protein Production Process

Vaccines and Gene Therapy Production Process

Market Drivers

Market Restraints

Regulatory Landscape—Biologics

Market Engineering Measurements

Revenue Forecast

Percent Revenue Breakdown by Region

Percent Revenue Breakdown by Biologic Drug Class

Global Trends in Biologics Market

Global Technology Trends in Biologics

Global Significant Expansions by Top Biopharma Companies and CMOs

Global Major Acquisitions by Top Biopharma Companies and CMOs

Top Biopharmaceutical Companies and Their Future Plans by 2020

Biologic Drug Pipeline across Therapeutic Categories and Biologic Class by Major Companies

Biologic Drugs Pipeline of Key Companies

Biologics API Market—Product Matrix

Porter’s Five Forces Analysis

Global Contract Manufacturing Partnerships

Best Practices in the Biopharma Industry

The Last Word

Legal Disclaimer

Major Companies

List of Figures
  • 1. Total Biologics API Market: Key Market Drivers, Global, 2016–2020
  • 2. Total Biologics API Market: Key Market Restraints, Global, 2016–2020
  • 3. Total Biologics API Market: Market Engineering Measurements, Global, 2015
List of Charts
  • 1. Total Biologics API Market: Revenue Forecast, Global, 2012–2020
  • 2. Total Biologics API Market: Percent Revenue by Region, Global, 2015
  • 3. Total Biologics API Market: Percent Revenue Breakdown by Biologic Drug Class, Global, 2015
  • 4. Total Biologics API Market: Porter’s Five Forces Analysis, Global, 2015
Related Research
This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose diseases.” Biologic drugs are significantly derived from monoclonal antibodies, recombinant proteins, vaccines, and others (e.g., cell therapy, gene therapy, antibody drug conjugates). In this study, drivers, restraints, and the competitive landscape as well as outsourcing and market and technology trends are discussed. Estimates and forecasts for the global market are provided from 2016 to 2020.
More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Key Findings~ ||| Segment Growth Trends~ ||| Technology Trend and Market Activities~ ||| In-house vs. Outsourcing~ || CEO’s Perspective~ | Total Biologics API Market—An Overview~ || Market Definitions~ || An Overview~ ||| Monoclonal antibodies~ ||| Recombinant proteins~ ||| Biologic vaccines~ || Global Biologics API Product Segmentation and Therapeutic Categories~ || Antibody and Recombinant Protein Production Process~ || Vaccines and Gene Therapy Production Process~ | Market Drivers and Restraints~ || Market Drivers~ ||| Patent expiry of biologic drugs in the next 5 years~ ||| Rising disease population in therapeutic categories like oncology, cardiology, auto-immune, and diabetes~ ||| High priced biologic drugs along with growth in biosimilars~ || Market Restraints~ ||| Complexity in biologic API manufacturing~ ||| Regulatory scrutiny concerning quality policies and user fees for drug manufacturing~ || Regulatory Landscape—Biologics~ | Forecast and Trends~ || Market Engineering Measurements~ || Revenue Forecast~ || Percent Revenue Breakdown by Region~ || Percent Revenue Breakdown by Biologic Drug Class~ | Technology and Market Trends~ || Global Trends in Biologics Market~ ||| In-house vs. Outsourcing~ ||| Biosimilars Growth~ ||| Hybrid Methodology~ ||| Nanobodies~ || Global Technology Trends in Biologics~ ||| Single-use Systems~ ||| Replacement Technologies~ ||| Process Analytical Technology~ ||| Continuous Manufacturing~ ||| Green Chemistry~ || Global Significant Expansions by Top Biopharma Companies and CMOs~ || Global Major Acquisitions by Top Biopharma Companies and CMOs~ | Competitive Analysis~ || Top Biopharmaceutical Companies and Their Future Plans by 2020~ ||| Roche~ ||| Amgen~ ||| Sanofi~ ||| Novo Nordisk~ ||| Abbvie~ ||| J&J~ || Biologic Drug Pipeline across Therapeutic Categories and Biologic Class by Major Companies~ || Biologic Drugs Pipeline of Key Companies~ || Biologics API Market—Product Matrix~ || Porter’s Five Forces Analysis~ | In-house vs. Outsourcing~ || Global Contract Manufacturing Partnerships~ || Best Practices in the Biopharma Industry~ || The Last Word~ ||| Growth segments~ ||| Technologies for the future~ ||| Outsourcing strategy~ || Legal Disclaimer~ | Appendix~ || Major Companies~ | The Frost & Sullivan Story~
List of Charts and Figures 1. Total Biologics API Market: Key Market Drivers, Global, 2016–2020~ 2. Total Biologics API Market: Key Market Restraints, Global, 2016–2020~ 3. Total Biologics API Market: Market Engineering Measurements, Global, 2015~| 1. Total Biologics API Market: Revenue Forecast, Global, 2012–2020~ 2. Total Biologics API Market: Percent Revenue by Region, Global, 2015~ 3. Total Biologics API Market: Percent Revenue Breakdown by Biologic Drug Class, Global, 2015~ 4. Total Biologics API Market: Porter’s Five Forces Analysis, Global, 2015~
Author Arun Ramesh
Industries Chemicals and Materials
WIP Number NE20-01-00-00-00
Is Prebook No